Streetbeat News

Regulatory

CRLBF

CURLF

MSOS

VRNOF

The Benzinga Cannabis Capital Conference highlighted optimism in the cannabis industry, focusing on potential federal reforms like rescheduling and the SAFE Banking Act. Key industry leaders discussed the impact of these changes on taxation and banking access, with companies like Verano, Curaleaf, and Cresco Labs positioning for growth. The conference emphasized the importance of adaptability and technological innovation in the evolving market.

Portfolio Pulse from Javier Hasse

October 11, 2024 | 6:38 pm

SPY

USO

The U.S. Treasury Department has expanded targeted sanctions on Iran's petroleum and petrochemical sectors in response to an attack on Israel. This move could impact global oil supply and prices.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 6:35 pm

CZR

DKNG

PENN

WYNN

The UK Labour Party is considering a tax increase on gambling firms, potentially raising up to £3 billion. This move could impact companies with significant operations in the UK, including US-listed gambling firms.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 6:33 pm

GNRC

SPY

Donald Trump announced a policy allowing retroactive tax deductions for home generator purchases starting September 1st, 2024. This could impact companies like Generac Holdings (GNRC), which manufactures generators.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 6:00 pm

GOOG

Scotiabank analyst Nat Schindler initiated coverage on Alphabet Inc. (NASDAQ:GOOG) with a Sector Outperform rating and a price target of $212, citing Google's strong position in AI and resilience to macroeconomic factors. Despite antitrust actions, the outlook remains positive.

Portfolio Pulse from Lekha Gupta

October 11, 2024 | 5:55 pm

SPY

President Biden highlighted the significant damage caused by recent storms, estimating $50 billion in damage from Milton alone. He emphasized the need to strengthen the U.S. power grid and plans to request additional funding from Congress.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 5:38 pm

PFE

The U.S. FDA has approved Pfizer's HYMPAVZI for treating hemophilia A or B in patients without inhibitors. This is the first once-weekly subcutaneous prophylactic treatment for hemophilia B and the first to use a pre-filled pen or syringe for hemophilia A or B.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 5:24 pm

LUCY

Innovative Eyewear has received FCC approval for new versions of its ChatGPT-enabled eyewear, potentially enhancing its product offerings and market position.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 5:03 pm